Cover Image
市場調查報告書

Vichem Chemie Research Ltd.:產品平台分析

Vichem Chemie Research Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 293923
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
Vichem Chemie Research Ltd.:產品平台分析 Vichem Chemie Research Ltd. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 46 Pages
簡介

Vichem Chemie Research Ltd. 是致力於使用激酶抑制劑的信號傳達療法的研究開發的生物科技研究型企業。提供激化酵素抑制劑庫,體外生物學,ADMET的最佳化,藥物發明標的蛋白質的提高等,各種服務。

這份報告提供Vichem Chemie Research Ltd.的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、後期階段及中止的計劃相關資訊等。

Vichem Chemie Research Ltd.的基本資料

  • Vichem Chemie Research Ltd.概要
  • 主要資訊
  • 企業資料

Vichem Chemie Research Ltd.:R&D概要

  • 主要的治療範圍

Vichem Chemie Research Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Vichem Chemie Research Ltd.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Vichem Chemie Research Ltd.:藥物簡介

  • 中樞神經系統、自體免疫疾病小分子
  • HIV-第一型感染疾病 CDK9 抑制小分子
  • VID-45110
  • BBH-7
  • BTP-15
  • 未公佈的症狀的 VEGFR2 拮抗小分子
  • 非小細胞肺癌、肺腺癌的 EGFR 阻礙細分
  • 急性骨髓白血病的 FLT3 抑制小分子
  • 癌症、細菌感染疾病 的PLK1 抑制小分子
  • 未公佈的症狀的 ROCK2 抑制小分子
  • 慢性心臟疾病的小分子
  • 大腸菌感染疾病的小分子
  • 多發性骨髓瘤的小分子
  • 腫瘤學的 HGFR/EGFR 拮抗小分子
  • 腫瘤學的 Pan FGFR 拮抗小分子
  • 腫瘤學的 PDGFR-beta 拮抗小分子
  • 腫瘤學的Aurora-A激酶 抑制小分子
  • 腫瘤學的Aurora-B激酶 抑制小分子
  • 腫瘤學的抑制小分子 CDK4
  • VCC-405567
  • VCC-668662

Vichem Chemie Research Ltd.:開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Vichem Chemie Research Ltd.:暫停中的計劃

Vichem Chemie Research Ltd.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07402CDB

Summary

Global Markets Direct's, 'Vichem Chemie Research Ltd. - Product Pipeline Review - 2015', provides an overview of the Vichem Chemie Research Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vichem Chemie Research Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Vichem Chemie Research Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Vichem Chemie Research Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Vichem Chemie Research Ltd.'s pipeline products

Reasons to buy

  • Evaluate Vichem Chemie Research Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Vichem Chemie Research Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Vichem Chemie Research Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Vichem Chemie Research Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vichem Chemie Research Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Vichem Chemie Research Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vichem Chemie Research Ltd. Snapshot
    • Vichem Chemie Research Ltd. Overview
    • Key Information
    • Key Facts
  • Vichem Chemie Research Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Vichem Chemie Research Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd. - Pipeline Products Glance
    • Vichem Chemie Research Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd. - Drug Profiles
    • Small Molecule for Central Nervous System and Autoimmune Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit CDK9 for HIV-1 Infection
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VID-45110
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BBH-7
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BTP-15
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize VEGFR2 for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit EGFR for Non-Small Cell Lung Cancer and Lung Adenocarcinoma
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small molecule to Inhibit FLT3 for Acute Myeloid Leukemia
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit PLK1 for Cancer and Bacterial Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit ROCK2 for Undisclosed Indication
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Chronic Heart Failure
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Escherichia Coli Infections
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Multiple Myeloma
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize HGFR and EGFR for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize Pan FGFR for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize PDGFR-beta for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Aurora A Kinase for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Aurora B Kinase for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit CDK4 for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCC-405567
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VCC-668662
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Vichem Chemie Research Ltd. - Pipeline Analysis
  • Vichem Chemie Research Ltd. - Pipeline Products by Target
  • Vichem Chemie Research Ltd. - Pipeline Products by Molecule Type
  • Vichem Chemie Research Ltd. - Pipeline Products by Mechanism of Action
  • Vichem Chemie Research Ltd. - Dormant Projects
  • Vichem Chemie Research Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vichem Chemie Research Ltd., Key Information
  • Vichem Chemie Research Ltd., Key Facts
  • Vichem Chemie Research Ltd. - Pipeline by Indication, 2015
  • Vichem Chemie Research Ltd. - Pipeline by Stage of Development, 2015
  • Vichem Chemie Research Ltd. - Monotherapy Products in Pipeline, 2015
  • Vichem Chemie Research Ltd. - Partnered Products in Pipeline, 2015
  • Vichem Chemie Research Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
  • Vichem Chemie Research Ltd. - Preclinical, 2015
  • Vichem Chemie Research Ltd. - Discovery, 2015
  • Vichem Chemie Research Ltd. - Pipeline by Target, 2015
  • Vichem Chemie Research Ltd. - Pipeline by Molecule Type, 2015
  • Vichem Chemie Research Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Vichem Chemie Research Ltd. - Dormant Developmental Projects,2015

List of Figures

  • Vichem Chemie Research Ltd. - Pipeline by Top 10 Indication, 2015
  • Vichem Chemie Research Ltd. - Pipeline by Stage of Development, 2015
  • Vichem Chemie Research Ltd. - Monotherapy Products in Pipeline, 2015
  • Vichem Chemie Research Ltd. - Pipeline by Top 10 Target, 2015
  • Vichem Chemie Research Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Vichem Chemie Research Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top